Abstract 1826: <i>In vivo</i> evaluation of NK-TICA®, a novel Bicycle® tumor-targeted immune cell agonist (TICA) designed to engage NK cells

Authors: Lukas Stanczuk, Johanna Lahdenranta, Fay J. Dufort, Christopher J. Leitheiser, Punit Upadhyaya, Philip E. Brandish, Nicholas Keen

Published: 2023-04-04

DOI: 10.1158/1538-7445.am2023-1826

Source: Full article